Reports a cancer-associated mutation disrupting STIL-BRCA1 interaction, leading to genomic instability.
Centrosome abnormalities can lead to erroneous chromosome segregation during cell division, resulting in genomic instability. We identified a cancer-associated heterozygous missense mutation (S76L) in the centrosome protein STIL that promotes centrosome amplification and DNA damage. STIL was found to interact with BRCA1 regulating its stability; this, however, is disrupted by the S76L mutation. Mimicking the heterozygous state by overexpressing STIL-S76L redistributed BRCA1 from the nucleus to centrosomes and elevated centrosomal Aurora-A and PLK1 kinases that are responsible for centrosome amplification. Decreased nuclear BRCA1 in the mutant state induced DNA damage, which was rescued by co-expression of wild-type but not nuclear localization-deficient BRCA1. Despite amplified centrosomes, mutant cells maintain pseudo-bipolar spindle organization via kinesin HSET (KIFC1)-dependent clustering, a known cancer survival mechanism and potential therapeutic target. Together, our findings uncover a previously unrecognized STIL-BRCA1 regulatory axis that safeguards centrosome homeostasis and genome integrity. Impact statement Our study reveals a cancer-associated STIL mutation that disrupts its interaction with BRCA1, thereby destabilizing BRCA1 and leading to centrosome amplification and DNA damage.
No takes yet. Share an insight, caveat, or question.
Sanghi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: